Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.37 USD | -0.88% | -7.13% | +31.46% |
02-09 | Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $17 From $21, Maintains Perform Rating | MT |
02-07 | Transcript : Enanta Pharmaceuticals, Inc., Q1 2024 Earnings Call, Feb 07, 2024 |
Sales 2024 * | 68.81M 94.06M | Sales 2025 * | 73.31M 100M | Capitalization | 262M 358M |
---|---|---|---|---|---|
Net income 2024 * | -110M -150M | Net income 2025 * | -116M -159M | EV / Sales 2024 * | 3.8 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.57 x |
P/E ratio 2024 * |
-2.37
x | P/E ratio 2025 * |
-2.51
x | Employees | 145 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.9% |
Latest transcript on Enanta Pharmaceuticals, Inc.
1 day | -0.88% | ||
1 week | -7.13% | ||
Current month | -29.15% | ||
1 month | -22.45% | ||
3 months | +1.14% | ||
6 months | +46.56% | ||
Current year | +31.46% |
Managers | Title | Age | Since |
---|---|---|---|
Jay Luly
CEO | Chief Executive Officer | 67 | 03-06-30 |
Paul Mellett
DFI | Director of Finance/CFO | 68 | 03-08-31 |
Chief Tech/Sci/R&D Officer | 50 | 22-08-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Foletta
BRD | Director/Board Member | 63 | 20-06-28 |
Lesley Russell
BRD | Director/Board Member | 63 | 16-11-17 |
Bruce Carter
CHM | Chairman | 80 | 13-11-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.10% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 12.37 | -0.88% | 67,161 |
24-04-25 | 12.48 | -3.41% | 79,696 |
24-04-24 | 12.92 | -1.75% | 90,291 |
24-04-23 | 13.15 | -2.16% | 108,198 |
24-04-22 | 13.44 | +0.90% | 67,129 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.46% | 262M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ENTA Stock